High risk of COVID-19 mortality with neurological diseases, vaccine effective in some MS patients
05 Jun 2021
byNatalia Reoutova
A territory-wide study carried out by the Chinese University of Hong Kong (CUHK) finds that patients with neurological diseases, especially stroke and Parkinson’s disease (PD), are at high risk of mortality if infected with severe acute respiratory syndrome coronavirus (SARS-CoV)–2 or SARS-CoV, while data from Israel show that the BNT162b2 vaccine does not increase the risk of relapse and is effective in multiple sclerosis (MS) patients, apart from those on certain types of MS medication.
